Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...

The list includes Novo Nordisk’s blockbuster diabetes injection Ozempic, weight loss shot Wegovy and diabetes pill Rybelsus, ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

It can cut decision-making time from days to minutes and dramatically improve results. by Ishai Menache, Jeevan Pathuri, David Simchi-Levi and Tom Linton Companies face a variety of complex ...

Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...

The company said it overestimated demand of its obesity and diabetes drugs in the fourth quarter, but projected a further ...

Copyright 2025 The Associated Press. All Rights Reserved. Patient Lory Osborn (right) speaks with Dr. Laura Davisson, director of the Medical Weight Management at ...

CHARLESTON, W.Va. — Lory Osborn says the Wegovy she was prescribed 15 months ago did more than help her lose 75 pounds — over a quarter of her body weight. The administrative assistant at West ...

Eli Lilly introduced Zepbound after receiving US FDA approval in November 2023. Credit: Andrey_Popov via Shutterstock. Eli Lilly and Novo Nordisk have been competing in the obesity market for the past ...

Novo Nordisk Ozempic (semaglutide) Wegovy Rybelsus Eli Lilly Mounjaro Zepbound GLP-1 drug manufacturing Supply Chain CDMO drug shortage Diabetes Obesity Facilities Manufacturing Pharma ...

Elon Musk shared a social media post that may point to a recent weight loss. The post shared Musk's personal history with weight-loss drugs, including the one he currently prefers. Get daily trade ...